$0.63 -0.02 (%) CEL-SCI Corp (New) - AMEX

Dec. 22, 2014 | 03:18 PM

Partner Headlines

  1. CEL-SCI Quarterly Patient Enrollment In Its Head And Neck Cancer Phase III Trial Increases Eight Fold Over Same Prior Year Period

    Benzinga | Dec. 2, 2014 | 08:31AM EST
  2. CEL-SCI Enrolls 22 Patients During October In Its Phase III Immunotherapy Head And Neck Cancer Trial

    Benzinga | Nov. 3, 2014 | 08:33AM EST
  3. Morning Market Losers

    Benzinga | Apr. 14, 2014 | 09:48AM EST
  4. Morning Gainers for Friday, March 14, 2014

    Benzinga | Mar. 14, 2014 | 10:09AM EST
  5. Mid-Day Gainers Mar. 7, 2014: SKUL, SMSI, DLIA, BIG, CVM, KFY, GTAT

    Benzinga | Mar. 7, 2014 | 11:26AM EST
  6. Morning Movers for Mar. 7, 2014: SKUL, DLIA, BIG, GTAT, CCRN, FL Moving Higher; NLNK, FEYE, SWY, FCEL Lower

    Benzinga | Mar. 7, 2014 | 09:04AM EST
  7. CEL-SCI Says Navy Okays Commencement of Co.'s Phase I Trial for Treatment of Anal Warts in HIV/HPV Co-Infected Patients

    Benzinga | Feb. 3, 2014 | 08:41AM EST
  8. CEL-SCI Prices $3.0M Unit at $0.63/Unit

    Benzinga | Dec. 19, 2013 | 09:21AM EST
  9. CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants

    Benzinga | Dec. 18, 2013 | 16:23PM EST
  10. CEL-SCI Warrants to Trade Under Ticker Symbol 'CSCIW'

    Benzinga | Dec. 9, 2013 | 12:44PM EST
  11. CEL-SCI Receives Bosnia and Herzegovina Approval to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

    Benzinga | Dec. 5, 2013 | 08:10AM EST
  12. CEL-SCI Receives Croatian Government Approval to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

    Benzinga | Nov. 12, 2013 | 09:46AM EST
  13. CEL-SCI, Ergomed Announce Co-Development, Profit Sharing Deal for Multikine in HIV/HPV

    Benzinga | Oct. 15, 2013 | 08:03AM EST
  14. Morning Market Losers

    Benzinga | Oct. 8, 2013 | 09:58AM EST
  15. CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants

    Benzinga | Oct. 7, 2013 | 16:06PM EST
  16. CEL-SCI Reports CRADA with Naval Medical Center in San Diego

    Benzinga | Oct. 7, 2013 | 09:44AM EST
  17. CEL-SCI Says NYSE MKT Approves Plan to Return Co. to Listing-Standards Compliance

    Benzinga | Sep. 3, 2013 | 08:05AM EST
  18. CEL-SCI Corporation to Raise $10.5M in Registered Direct Offering

    Benzinga | Dec. 4, 2012 | 02:16AM EST
  19. Cognizant Technology, Sohu.com Among Stocks Gapping Up Monday

    FoxBusiness | Aug. 6, 2012 | 04:31AM EST
  20. Smith \x26 Wesson Holding Corporation, ValueClick Among Stocks Gapping Up Friday

    FoxBusiness | Jun. 29, 2012 | 04:31AM EST
  21. CEL-SCI Corporation Gapping Down Tuesday

    FoxBusiness | Jun. 19, 2012 | 04:31AM EST
  22. CEL-SCI Will Sell 16M Shares at $0.35

    Benzinga | Jun. 19, 2012 | 03:15AM EST
  23. Cel-Sci Says Phase III Clinical Trial Moving Forward

    Benzinga | May. 10, 2012 | 10:12AM EST
  24. CEL-SCI Corporation to Raise $5.76M in Registered Direct Offering

    Benzinga | Jan. 26, 2012 | 02:15AM EST
  25. CEL- SCI Corporation Authorizes Expansion of Phase III Clinical Trial to an Additional 4 European Countries

    Benzinga | Dec. 27, 2011 | 01:45AM EST
  26. CEL- SCI Corporation Updates Positive Phase III Clinical Activities for Investigational Cancer Therapy Multikine

    Benzinga | Dec. 7, 2011 | 02:44AM EST
Trading Center